⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9805585 | 0.83 | NPC1 (0.44) | — | |
| SCHEMBL2555506 | 0.80 | ALDH1A1 (0.39) | — | |
| SCHEMBL2555511 | 0.80 | ALDH1A1 (0.39) | — | |
| SCHEMBL6738767 | 0.76 | — | — | |
| SCHEMBL17273633 | 0.76 | — | — | |
| SCHEMBL31171647 | 0.76 | — | — | |
| SCHEMBL1241251 | 0.76 | — | — | |
| SCHEMBL17790918 | 0.76 | — | — | |
| SCHEMBL16761877 | 0.75 | KCNJ1 (0.44) | — | |
| SCHEMBL30893537 | 0.75 | KCNJ1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2013 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122057564-A | Preparation method of all-organic ionic liquid limited-domain nano catalytic material and photocatalytic CO (carbon monoxide)2Application in methanation | 黑龙江大学 | 2026-05-19 | — | — | CN | claimed |
| CN-120117949-A | Method for directly preparing tertiary amine compound from aromatic aldehyde, ketone and secondary amine | 湖南大学 | 2025-06-10 | — | — | CN | claimed |
| CN-120025282-A | Synthesis method of N-heterocyclic carbene precursor and metal complex based on nano graphene fragments | 西北大学 | 2025-05-23 | — | — | CN | claimed |
| CN-118908184-B | Preparation method and application of boron-nitrogen co-doped porous carbon material | 泰苓科技(湖州)有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-118908184-A | Preparation method and application of boron-nitrogen co-doped porous carbon material | 泰苓科技(湖州)有限公司 | 2024-11-08 | — | — | CN | claimed |
| CN-117304096-A | 4- (2-formylpyridyl) azobenzene compound and synthesis and application thereof | 浙江理工大学 | 2023-12-29 | — | — | CN | claimed |
| CN-116947754-A | Antitumor compound, antitumor drug, preparation method and application | 北京中医药大学 | 2023-10-27 | — | — | CN | claimed |
| CN-110423234-B | Thiosemicarbazone derivative containing indole fragment and preparation method and application thereof | 郑州大学 | 2020-06-30 | — | — | CN | claimed |
| CN-110423234-A | Thiosemicarbazone derivative of the segment containing indoles and its preparation method and application | UNIV ZHENGZHOU | 2019-11-08 | — | — | CN | claimed |
| CN-110078659-A | A kind of isodextropimaric acid heterocycle acylhydrazone and its preparation method and application | 中国林业科学研究院林产化学工业研究所 | 2019-08-02 | — | — | CN | claimed |
| EP-2245132-B1 | ENCAPSULATED BENEFIT AGENT | UNILEVER PLC NO 41424 (GB) | 2017-10-18 | — | — | EP | claimed |
| CN-102015993-B | Encapsulated benefit agent | UNILEVER PLC | 2013-03-27 | — | — | CN | claimed |
| CN-102015993-A | Encapsulated benefit agent | UNILEVER PLC | 2011-04-13 | — | — | CN | claimed |
| EP-2245132-A1 | ENCAPSULATED BENEFIT AGENT | Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House (GB) | 2010-11-03 | — | — | EP | claimed |
| WO-2009103576-A1 | ENCAPSULATED BENEFIT AGENT | UNILEVER PLC (GB) | 2009-08-27 | — | — | WO | claimed |
| WO-2008133344-A2 | PIPERIDINE DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-11-06 | — | — | WO | claimed |
| US-20080275085-A1 | Piperidine derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-11-06 | — | — | US | claimed |
| WO-2026107227-A1 | COMPOSITIONS COMPRISING USP1 INHIBITORS AND METHODS OF USING THE SAME | EIKON THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-1992017469-A2 | N-ARYLHETEROARYLALKYL IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-10-15 | — | — | WO | disclosed |
| EP-0508393-A1 | N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders | G.D. Searle & Co. (US) | 1992-10-14 | — | — | EP | disclosed |